Glidelogic Launches Latest Version of ResearchMind Featuring OpenAI GPT-5 and Anthropic Claude Opus 4.1 - Pro Version Remains Free for Academic Partners
LAS VEGAS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- â via IBN -- Glidelogic Corp. (USOTC: GDLG, "Glidelogic", "the Company") today announced the official global release of the latest version of ResearchMind, following four months of invitation-only beta testing since its debut on April 1, 2025. The platform now integrates advanced AI capabilities and is available at just $24.99 per full analysis report.
Related Questions
What is the expected adoption rate among academic partners, and how might the free Pro version affect overall revenue and margin?
How will the product impact Glidelogicâs overall earnings guidance for 2025â2026?
How does the platformâs performance (accuracy, speed) compare to the baseline GPTâ4 and other AI models, and what impact could that have on customer retention?
What are the potential risks of AI bias or regulatory scrutiny that could affect the platformâs adoption or cause liability?
How will the launch of ResearchMind with GPT-5 and Claude Opus 4.1 affect GDLG's stock price in the short and long term?
Will the product generate recurring revenue (e.g., subscriptions, API usage) beyond oneâoff report sales?
What is the expected revenue impact from selling full analysis reports at $24.99 each?
How many reports does Glidelogic forecast selling per quarter and what assumptions underlie those forecasts?
What is the size and growth rate of the market for AIâdriven research platforms?
How does ResearchMind's pricing and feature set compare to competing products (e.g., Bloomberg Terminal AI addâons, Refinitiv, Bloomberg, FactSet, and other AIâenhanced research tools)?
Are there any licensing or royalty costs associated with using OpenAI GPTâ5 and Anthropic Claude Opus 4.1 that could impact profitability?
What is the projected cost structure (cloud compute, licensing, R&D) for delivering each $24.99 report?
What is the timeline for expanding the platform beyond the U.S. market and what regulatory hurdles exist?
Are there any intellectualâproperty or partnership risks with OpenAI and Anthropic that could affect the productâs continuity?
What are the key metrics (e.g., reports per user, churn rate, conversion from free academic version to paid) that will drive future growth?
Will the free Pro version for academic partners generate a pipeline of paid enterprise customers later?
How does the launch affect the competitive landscape and could it prompt price or feature competition from other AIâdriven research providers?
What is the expected impact on Glidelogic's gross margins and operating expenses?
Will the new AI capabilities enable crossâselling of other Glidelogic products or services?
How will the launch be reflected in analyst forecasts and target price revisions?